Drug Channels
Drug Channels is a leading online publication on pharmaceutical economics published by Drug Channels Institute, an HMP Global company
- Website
- drugchannels.net · all feeds from this site
- Feed URL
https://www.drugchannels.net/feeds/posts/default?alt=rss
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Biopharma’s AI Fork in the Road
Today's guest post comes from Danny Sigurdson, Founder and CEO at Courier Health. Danny examines how biopharma companies are approaching patient services, partner changes, and artificial intelligence in 2027. He argues that connected data and purpose-built technology can improve…
-
"How Do I Know I'm Not Just Giving Money Away?" The Question Every Market Access Leader Is Asking
Today's guest post comes from Anurati Mathur, Co-Founder & CEO at Sempre Health. Drawing on conversations with pharmaceutical market access leaders, Anurati examines whether traditional copay assistance programs are delivering sufficient value. She argues that automatic…
-
Drug Channels News Roundup, October 2026: Part D’s Hidden Cost Sharing Gap, 340B’s $244 Billion Footprint, The Net Price Rebate Model, Cigna’s Wholesale Push, and Four Ways to Bag a Drug
By Bryce Platt, PharmD Fall has brought a fresh round of questions about how drug channel economics affect patients, plans, and providers. Take a break between your work sets to catch up on some quality resources for understanding the drug channel. In this issue: Part D's Hidden…
-
Copay + GTN Revenue Protection = Better Together
Today's guest post comes from Gerard Rivera, Co-Founder & CEO at RIS Rx. Gerard Rivera examines how copay programs and real-time gross-to-net (GTN) revenue protection can work together to support patient access and program performance. He highlights how simpler program design,…
-
Alternative PBM Satisfaction Declined in 2026, Shrinking the Advantage Over the Big Three PBMs
By Bryce Platt, PharmD PBMs outside the Big Three still earn higher customer satisfaction ratings, but their lead has nearly disappeared. Meanwhile, plan sponsors are inviting alternatives into their RFPs, and some are changing vendors. Research on 2027 benefits planning…
-
Informa's Trade and Channel Strategies
December 8-10, 2026, W Philadelphia Exclusive Offer—Use promo 26DC10 to save 10%* NAVIGATE THE CONVERGENCE: PREPARE, DON'T PREDICT In the next eighteen months, every assumption of pharmaceutical channel strategy breaks all at once. The patent cliff, WAC reductions, loss of…
-
10 Crucial Trends Facing U.S. Drug Wholesalers in 2026 and Beyond
By Adam J. Fein, Ph.D. As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. During…
-
NOW AVAILABLE: DCI’s New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels Institute is pleased to announce the availability of our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors . The U.S. prescription drug market continues to expand, even as the foundations of the drug channel are shifting. Legislative…
-
Transparency is No Longer a Compliance Issue
Today's guest post comes from Meghal Patel, Chief Product Officer for Truzo at Model N. Meghal examines why claims-level transparency has become increasingly important as manufacturers navigate the growing complexity of 340B and other drug pricing programs. He argues that…
-
The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs (rerun)
This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors . Click here to see the original post from June 2026. By Bryce Platt, PharmD For years, Medicare Part D…
-
2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges (rerun)
This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors . Click here to see the original post from July 2026. By Adam J. Fein, Ph.D. Every year, Drug Channels…
-
Pharmacist Salaries and Employment in 2025: Retail Declines, Hospital Gains (rerun)
This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors . Click here to see the original post from June 2026. By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time…
-
Informa’s PBM Contracting Summit
Informa’s PBM Contracting Summit December 8-9, 2026 | Chicago, IL Drug Channels readers save 10% with code 26DRCH10* The PBM Contracting Summit returns to Chicago this December! Join the industry as expert speakers navigate the complex PBM landscape, gaining unparalleled…
-
Patient Support Strategy by Lifecycle Stage: Launch, Growth, Maturity, and Loss of Exclusivity
Today's guest post comes from Kristen Magee, Vice President of Methodology & Enablement at AssistRx. Kristen explains why patient support programs (PSPs) need to evolve as products move from launch through growth, maturity, and loss of exclusivity. She outlines how manufacturers…
-
Drug Channels News Roundup, September 2026: The 340B Margin Squeeze, Economics of Cutting List Price, Patient Adherence from Copay Cards, Negative Part D Premiums, and Drug Channel Dating Profiles
By Bryce Platt, PharmD Football season is officially back. Personally, my signal is hearing my uncle curse about bad calls from 1,000 miles away, but you may have already seen a game. This news roundup is short enough to fit into an ad break or two. *Caveat: may lead to rabbit…
-
Why GoodRx Is Built for the AI-Driven Patient Journey
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines how AI-powered search and conversational tools are reshaping the way patients research treatments and prescription costs before ever reaching a brand's website. She argues…
-
The Spinoff: How Biosimilars Are Becoming Wholesalers' Next Hit Show
By Bryce Platt, PharmD For more than a decade, the answer to “Where do drug wholesalers make their money?” has been generic drugs. Although wholesaler revenues are linked most closely to sales of brand-name drugs, the majority of wholesalers’ gross profits comes from generic…
-
Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services Congress
Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services Congress November 17-20, 2026 | Sheraton Downtown Philadelphia Exclusive Offer – Use promo code 26DC10 to save 10% on your registration* Patient need is at an all-time…
-
Fixing the Front Door Isn’t the Same as Fixing Time to Therapy
Today's guest post comes from Tom Traylor, Senior Vice President of Pharmacy Operations at CareMetx. Tom examines how intake speed and time to therapy relate to each other in specialty pharmacy programs. He describes how bringing pharmacy connectivity to the front of the patient…
-
Preorder DCI’s New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
On October 12, 2026, Drug Channels Institute will release our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors . The U.S. prescription drug market continues to expand, but the foundations of the drug channel are shifting. Legislative intervention,…